These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8113882)

  • 1. Differential diagnosis of Alzheimer's disease with PET.
    Salmon E; Sadzot B; Maquet P; Degueldre C; Lemaire C; Rigo P; Comar D; Franck G
    J Nucl Med; 1994 Mar; 35(3):391-8. PubMed ID: 8113882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
    J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomographic study in Alzheimer's disease and Pick's disease.
    Salmon E; Franck G
    Arch Gerontol Geriatr Suppl; 1989; 1():241-7. PubMed ID: 2787995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E
    J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography.
    Salmon E; Gregoire MC; Delfiore G; Lemaire C; Degueldre C; Franck G; Comar D
    J Cereb Blood Flow Metab; 1996 May; 16(3):399-408. PubMed ID: 8621744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can PET data differentiate Alzheimer's disease from vascular dementia?
    Nagata K; Maruya H; Yuya H; Terashi H; Mito Y; Kato H; Sato M; Satoh Y; Watahiki Y; Hirata Y; Yokoyama E; Hatazawa J
    Ann N Y Acad Sci; 2000 Apr; 903():252-61. PubMed ID: 10818514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of cerebral blood flow by SPECT: a valuable tool in the investigation of dementia?
    Weinstein HC; Hijdra A; van Royen EA; Derix MM
    Clin Neurol Neurosurg; 1989; 91(1):13-9. PubMed ID: 2538276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
    Jagust WJ; Reed BR; Seab JP; Kramer JH; Budinger TF
    Am J Physiol Imaging; 1989; 4(3):89-96. PubMed ID: 2789844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies.
    Devous MD
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1685-96. PubMed ID: 12458405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET and differential diagnosis of dementia.
    Herholz K
    Alzheimer Dis Assoc Disord; 1995; 9(1):6-16. PubMed ID: 7605624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral blood flow and cerebral oxygen metabolism in patients with dementia of frontal lobe type].
    Kitamura S; Araki T; Sakamoto S; Iio M; Terashi A
    Rinsho Shinkeigaku; 1990 Nov; 30(11):1171-5. PubMed ID: 2085920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography facilitates diagnosis of early-onset Alzheimer's disease.
    McMurtray AM; Licht E; Yeo T; Krisztal E; Saul RE; Mendez MF
    Eur Neurol; 2008; 59(1-2):31-7. PubMed ID: 17917455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
    Mielke R; Heiss WD
    J Neural Transm Suppl; 1998; 53():237-50. PubMed ID: 9700661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
    Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
    Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and pathological aging--findings of positron-emission-tomography.
    Mielke R; Kessler J; Szelies B; Herholz K; Wienhard K; Heiss WD
    J Neural Transm (Vienna); 1998; 105(8-9):821-37. PubMed ID: 9869321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical neurophysiology of dementia.
    Torres F; Hutton JT
    Neurol Clin; 1986 May; 4(2):369-86. PubMed ID: 2940455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heterogeneity of Alzheimer's disease].
    Scheltens P; Vermersch P; Leys D
    Rev Neurol (Paris); 1993; 149(1):14-25. PubMed ID: 8337557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early thalamic and cortical hypometabolism in adult-onset dementia due to metachromatic leukodystrophy.
    Salmon E; Van der Linden M; Maerfens Noordhout A; Brucher JM; Mouchette R; Waltregny A; Degueldre C; Franck G
    Acta Neurol Belg; 1999 Sep; 99(3):185-8. PubMed ID: 10544727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation variability of 18FDG-positron emission tomography studies in dementia.
    Hoffman JM; Hanson MW; Welsh KA; Earl N; Paine S; Delong D; Coleman RE
    Invest Radiol; 1996 Jun; 31(6):316-22. PubMed ID: 8761863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.